Highly Integrated Nanoplatform Based on an E‑Selectin-Targeting Strategy for Metastatic Breast Cancer Treatment

Therapeutic goals for metastatic breast cancer, including shrinkage of established metastasis and suppression of movement of tumor cells, are often hard to achieve and remain the main obstacles restricting the antimetastatic efficacy of targeted drug delivery systems (TDDSs). Herein, we proposed an...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Molecular pharmaceutics 2019-08, Vol.16 (8), p.3694-3702
Hauptverfasser:	Xu, Xiao-Ling, Zhu, Meng-Lu, Liu, Di, Shu, Gao-Feng, Qi, Jing, Lu, Yan, Wang, Fei, Ying, Xiao-Ying, Chen, Jian, Du, Yong-Zhong
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!